|
AbbVie to take Nimbles IL23R for psoriasis
|
Sun-15-12-2024, 12:37 PM
(Sat-14-12-2024, 23:51 PM)mataribot Wrote: I don’t see how an oral option for IL23 is going be better than the biologics. My guess it’s going to be worse overall. But guess will have to wait and see. Depends on how effectively is will pass the bowel into the body I guess. I love the idea of oral medication versus injections. |
|
« Next Oldest | Next Newest »
|
| Possibly Related Threads… | |||||
| Thread | Author | Replies | Views | Last Post | |
|
AbbVie and Boehringer Ingelheim to develop and commercialize BI 655066 | Fred | 9 | 11,189 |
Tue-27-09-2016, 18:50 PM Last Post: Fred |
|
|
AbbVie will present data on risankizumab at EADV | Fred | 3 | 6,314 |
Mon-26-09-2016, 17:07 PM Last Post: jiml |
|
|
Xenoport shares take a knock after phase 2 release | Fred | 0 | 2,546 |
Tue-15-09-2015, 20:09 PM Last Post: Fred |
|
|
Abbott announces AbbVie | Fred | 0 | 3,340 |
Thu-22-03-2012, 13:21 PM Last Post: Fred |
Health Boards
